Sarah Triggs
Health and Social Care Leader, Marsh McLennan UK Industries
-
United Kingdom
The NHS is navigating one of the most turbulent periods in its history. Global supply chain disruptions have emerged as a critical challenge, directly impacting patient care and operational efficiency. From geopolitical tensions and climate-related disruptions to rising demand pressures, the NHS supply chain is exposed to vulnerabilities of unprecedented scale and complexity. Addressing these challenges requires urgent attention and strategic action to safeguard the delivery of essential healthcare services.
Recent global events — such as disruptions in key shipping routes like those in the Red Sea — exposed the fragility of international supply chains, causing costly delays and supply shortages that reverberated across healthcare systems worldwide. The NHS, which depends on the prompt delivery of medical supplies, pharmaceuticals, and equipment, felt these disruptions acutely.
Over the past three years, pandemic-induced disruptions and geopolitical conflicts have led to medicine shortages, forcing community pharmacy teams to spend hours daily searching for scarce medicines. More recently, the near insolvency of a major healthcare equipment supplier to the NHS threatened to disrupt critical services for vulnerable patients.
Adding to the challenges faced by healthcare procurement teams are the effects of global tariffs, which have introduced significant cost pressures on international trade flows. Tariffs on medical equipment, pharmaceuticals, and raw materials are likely to increase procurement costs for many healthcare providers worldwide, including the NHS.
These challenges highlight the urgent need to build a more resilient, agile, and secure NHS supply chain.
With 65% of companies experiencing at least one bottleneck in their supply chain capable of causing catastrophic disruption, enhancing supply chain resilience is essential — not only for cost management but to uphold the NHS’s commitment to exceptional patient care.
Given the NHS’s annual expenditure of approximately £7.9 billion on medical equipment and consumables, and £19 billion on medicines, the following strategies could enhance supply chain efficiency within the NHS.
To safeguard the future of healthcare delivery, NHS leaders should consider the following actions:
While risks cannot be entirely eliminated, the NHS can strengthen its control by thoroughly understanding and addressing the complexities of its supply chain. By embracing diversification, transparency, financial vigilance, tariff cost mapping, and technology-driven insights, the NHS will be better positioned to withstand future disruptions, protect patient care, and deliver value for taxpayers.
Health and Social Care Leader, Marsh McLennan UK Industries
United Kingdom
Head of Multinational Clients, Marsh Advisory
United Kingdom